குப்தா பங்கு ஆராய்ச்சி இணை News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from குப்தா பங்கு ஆராய்ச்சி இணை. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In குப்தா பங்கு ஆராய்ச்சி இணை Today - Breaking & Trending Today

Glenmark Life Sciences IPO sails through on day 1, retail portion subscribed five times


The public issue received bids for 4.17 crore shares against total 1.50 crore shares on offer
Brokerages are positive on prospects of Glenmark Life Sciences IPO.
BusinessToday.In
Updated Jul 28, 2021, 10:27 AM IST
The initial public offer (IPO) of Glenmark Life Sciences was fully subscribed on its first day on Tuesday. The public issue received bids for 4.17 crore shares against total 1.50 crore shares on offer.
The portion reserved for retail investors was subscribed 5.16 times.
Portion allocated for non-institutional investors was subscribed 85 percent. Qualified institutional buyers put in bids for 10,540 equity shares against their reserved portion of 42.42 lakh equity shares.
The IPO will close on July 29. Price band for the offer has been fixed at Rs 695-720 per equity share. ....

Maruti Suzuki , Glenmark Pharma , Kotak Mahindra Capital Company , Capital Advisors Ltd , Insurance Company , Glenmark Life Sciences , Copthall Mauritius Investment Ltd , Government Pension Fund Global , Indusind Bank , Tata Motors , Oaktree Emerging Markets Equity Fund , Bofa Securities India Ltd , Goldman Sachs India Securities Private , Kuber India Fund , Investment Funds , Reliance General Insurance Company , Granules India , Securities Private Limited , Advisors Ltd , Bob Capital Markets , Gupta Equity Research Associate , Angel Broking , மாருதி ஸஸூகீ , க்ளேண்மர்க் பார்மா , கோட்டக் மஹிந்திரா மூலதனம் நிறுவனம் , காப்பீடு நிறுவனம் ,

Unichem Laboratories share rises 8% on US FDA approval for Apremilast tablets


Unichem Laboratories share rises 8% on US FDA approval for Apremilast tablets
The pharma share touched an intraday high of Rs 329.25, rising 7.74% on BSE
BusinessToday.In | February 19, 2021 | Updated 17:12 IST
Unichem Labs share stands higher than 5 day, 20 day, 50 day, 100 day and 200 day moving averages.
Unichem Laboratories share price rose nearly 8 percent today after United States Food and Drug Administration s (US FDA)  awarded approval for its Apremilast tablets. The stock has gained 6.9% in the last 4 days. The pharma share touched an intraday high of Rs 329.25, rising 7.74% on BSE.
Unichem Labs share stands higher than 5 day, 20 day, 50 day, 100 day and 200 day moving averages. The share has gained 131.55% in one year and risen 22.66% since the beginning of this year. Later, the small cap stock closed 4.94% or Rs 15.10 higher at Rs 320.70. ....

United States , Amgen Otezla , Drug Administration , Unichem Laboratories , United States Food , Apremilast Tablets , Gupta Equity Research Associate , Angel Broking , Unichem Laboratories Share Price , Unichem Laboratories Share Rises , ஒன்றுபட்டது மாநிலங்களில் , ஒன்றுபட்டது மாநிலங்களில் உணவு , குப்தா பங்கு ஆராய்ச்சி இணை , தேவதை தரகு ,